C-reactive protein and vasospasm after aneurysmal subarachnoid hemorrhage

Acta Cirurgica Brasileira

Volumn 29, Issue 5, 2014, Pages 340-345

  Romero, Flávio Ramalho ^a   Cataneo, Daniele Cristina ^a   Cataneo, Antonio José Maria ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

C Reactive protein; Intracranial; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANEURYSM RUPTURE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLASGOW OUTCOME SCALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SUBARACHNOID HEMORRHAGE; TERTIARY CARE CENTER; TRANSCRANIAL DOPPLER; VASOSPASM;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GLASGOW OUTCOME SCALE; HEMODYNAMICS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOSPASM, INTRACRANIAL; YOUNG ADULT;

EID: 84901259340     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502014000500009     Document Type: Article

References (29)

1. Bengzon J, Grubb A, Bune A, Heillstrom K, Lindstrom V, Brandt L. C-reactive protein levels following standard neurosurgical procedures. Acta Neurochir (Wien). 2003;145:667-71.
2. Romero FR, Bertolini EG, Figueiredo EG, Teixeira MJ. Serum C-reactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage. Arq Neuropsiquiatr. 2012;70(3):202-5.
3. Romero FR, Ducati LG, Zanini MA, Cataneo DC, Cataneo AMJ, Gabarra RC. Predicting vasospasm after subarachnoid hemohrrage with C reactive protein levels. Helth (Irvine). 2013;5(7A5):1-6.
4. Fountas KN, Tasiou A, Kapsalaki EZ, Paterakis KN, Grigorian AA, Lee GP. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Neurosurg Focus. 2009;26(5):22-31.
5. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck, TP. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery. 2008;62:422-30.
6. Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, Hirakawa K. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 1972;77:96-100.
7. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter Phase IIa study. Neurosurgery. 2005;103:9-17.
8. Goddard AJP, Raju PPJ, Gholkar A. Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome? J Neurol Neurosurg Psychiatry. 2004;75:868-72.
9. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol. 1990;65:168-72.
10. Carr WP. The role of the laboratory in rheumatology. Acute-phase proteins. Clin Rheum Dis. 1983;9:227-39.
11. Dumont AS, Dumont RJ, Chow MM, Lin C, Calisaneller T, Ley KF. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53:123-35.
12. Hansen-Schwartz J. Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology. Neurocrit Care. 2004;1:235-46.
13. Hergenroeder G, Redell JB, Moore AN, Dubinsky WP, Funk RT, Crommett J, Clifton GL, Levine R, Valadka A, Dash PK. Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intra-cranial pressure. J Neurotrauma. 2008;25:79-93.
14. Hoshi T, Shimizu T, Kito K, Yamasaki N, Takahashi K, Takahashi M. Immunological study of late cerebral vasospasm in subarachnoid hemorrhage: detection of immunoglobulins, C3, and fibrinogen in cerebral arterial walls by immunofluorescence method. Neuro Med Chir. 1984;24:647-54.
15. Mayberg MR, Batjer HH, Dacey RG Jr, Diringer M, Haley EC, Heros RC. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1984;25:2315-28.
16. Kasuya H, Weir BK, Nakane M, Pollock JS, Johns L, Marton LS. Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg. 1985;82:250-5.
17. Rothoerl RD, Schebesch KM, Kubitza M, Woertgen C, Brawanski A, Pina AL. ICAM-1 and VCAM-1 expression following aneurysmal subarachnoid hemorrhage and their possible role in the pathophysiology of subsequent ischemic deficits. Cerebrovasc Dis. 2006;22:143-9.
18. Rankin J. Cerebral vascular accidents in patients over the age of 60. Scott Med J. 1957;2:200-15.
19. Bonita R, Beaglehole R. Modification of Rankin Scale: recovery of motor function after stroke. Stroke. 1988;19(12):1497-1500.
20. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patient. Stroke. 1988;19(5):604-7.
21. Lynch JR, Blessing R, White WD, Gracott HP, Newman MF, Laskowitz DT. Novel diagnostic test for acute stroke. Stroke. 2004;35:57-63.
22. Suzuki H, Kanamaru K, Tsunoda H, Inada H, Kuroki M, Sun H. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest. 1999;104:59-66.
23. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther. 2005;105:23-56.
24. Mazlam MZ, Hodgson HJ. Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease. Gut. 2005;35:77-83.
25. Kassell NF, Sasaki T, Colohan ART, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1985;16:562-72.
26. Kasuya H, Weir BK, Nakane M, Pollock JS, Johns L, Marton LS. Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg. 1995;82:250-5.
27. Hung MJ, Cherng WJ, Yang NI, Cheng CW, Li LF. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol. 2005; 96:1484-90.
28. Deshmukh VR, Kakarla UK, Figueiredo EG, Zabramski JM, Spetzler RF. Long-term clinical and angiographic follow-up of unclippable wrapped intracranial aneurysms. Neurosurgery. 2006;58(3):434-42.
29. Cecon AD, Figueiredo EG, Bor-Seng-Shu E, Scaff M, Teixeira MJ. Extremely delayed cerebral vasospasm after subarachnoid hemorrhage. Arq Neuropsiquiatr. 2008;66(3A):554-6.